Clinical Trial Update: Scandinavian Candesartan Acute Stroke Trial (SCAST) [Phase 3]

View source ↗

Summary

This update reports the completion of the Phase 3 Scandinavian Candesartan Acute Stroke Trial (SCAST) evaluating candesartan in acute stroke.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Stroke

Drugs mentioned

• Atacand (candesartan)

Snippet

Sponsor: Ullevaal University Hospital | Conditions: Stroke | Phase 3 | Status: COMPLETED